These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38133666)

  • 21. Adjuvant chemotherapy improves long-term survival in pathologic stage III rectal mucinous adenocarcinoma after pre-operative chemoradiotherapy.
    Liao H; Li T; Liang Y; Liu Y; Yuan Y; Li M; Li A; Liu Y; Yao Y; Li T
    Int J Colorectal Dis; 2023 Aug; 38(1):207. PubMed ID: 37542591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
    Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
    Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propensity-score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II-III anal adenocarcinoma.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
    J Surg Oncol; 2023 Sep; 128(4):585-594. PubMed ID: 37183543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anastomotic leakage is associated with impaired overall and disease-free survival after curative rectal cancer resection: a propensity score analysis.
    Kulu Y; Tarantio I; Warschkow R; Kny S; Schneider M; Schmied BM; Büchler MW; Ulrich A
    Ann Surg Oncol; 2015; 22(6):2059-67. PubMed ID: 25348782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
    Delitto D; George TJ; Loftus TJ; Qiu P; Chang GJ; Allegra CJ; Hall WA; Hughes SJ; Tan SA; Shaw CM; Iqbal A
    J Natl Cancer Inst; 2018 May; 110(5):460-466. PubMed ID: 29165692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
    Song C; Song S; Kim JS; Oh HK; Kim DW; Lee KW; Kim JH; Eom KY; Kim IA; Kang SB
    PLoS One; 2015; 10(4):e0123657. PubMed ID: 25902069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant chemotherapy does not improve cancer-specific survival for pathologic stage II/III rectal adenocarcinoma after neoadjuvant chemoradiotherapy and surgery: evidence based on long-term survival analysis from SEER data.
    Liao H; Zeng T; Xie X; Li J; Li D; KejinYan ; Chen F; Zhu H
    Int J Colorectal Dis; 2023 May; 38(1):134. PubMed ID: 37199862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis.
    Ding M; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Xie X; Li J; Li W; Deng Y
    Clin Colorectal Cancer; 2022 Mar; 21(1):e12-e20. PubMed ID: 34963563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.
    Shahab D; Gabriel E; Attwood K; Ma WW; Francescutti V; Nurkin S; Boland PM
    Clin Colorectal Cancer; 2017 Dec; 16(4):300-307. PubMed ID: 28420585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
    Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
    Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical outcomes and predictors of overall survival of stage I-III appendiceal adenocarcinoma: Retrospective cohort analysis of the national cancer database.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Garoufalia Z; Gefen R; Wexner SD
    Surg Oncol; 2024 Feb; 52():102034. PubMed ID: 38211448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and prognostic factors in patients with rectal squamous cell carcinoma.
    Kommalapati A; Tella SH; Yadav S; Goyal G; Hallemeier C; Durgin L; Jin Z; Mahipal A
    Eur J Surg Oncol; 2020 Jun; 46(6):1111-1117. PubMed ID: 32201124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
    Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
    Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
    Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
    Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
    Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer.
    Ma SJ; Oladeru OT; Miccio JA; Iovoli AJ; Hermann GM; Singh AK
    JAMA Netw Open; 2019 Aug; 2(8):e199126. PubMed ID: 31411712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
    Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
    Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival and prognostic factors in patients with pancreatic squamous cell carcinoma.
    Tella SH; Kommalapati A; Yadav S; Bergquist JR; Truty MJ; Durgin L; Ma WW; Cleary SP; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Sep; 45(9):1700-1705. PubMed ID: 31118133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.